Quebec-based non-for-profit organization engages Novateur experts for business development and scientific due diligence advisory support
Since 2017, IRICoR has engaged Novateur’s team of experts for a number of mandates. Those included Business Development advisory, Competitive Landscape Analysis, Scientific Due Diligence, and Market Assessment for a number of its projects. Novateur continues to support IRICoR on a number of projects, including those being spun-off into new companies.
"Novateur Ventures, a leading global life sciences advisory firm, announced it has participated in the $13.6M (£10.3M) seed investment raised by Epitopea, a cancer therapeutics company recently spun out of the Université de Montréal (UdeM) / IRIC in partnership with IRICoR. This investment will support the further development and application of Epitopea’s ground-breaking approaches to identify shared, aberrantly expressed tumor-specific antigens (TSA), that Epitopea has exclusively licensed from UdeM."